Karen J Watson-Straughan

Title: Innovations by Karen J Watson-Straughan

Introduction

Karen J Watson-Straughan is an accomplished inventor based in Encinitas, California. She has made significant contributions to the field of biochemistry, particularly in the development of compounds aimed at treating sexual dysfunction. With a total of two patents to her name, her work has the potential to impact many lives.

Latest Patents

Her latest patents include "Triamine derivative melanocortin receptor ligands and methods of using same" and "Melanocortin receptor-3 ligands to treat sexual dysfunction." These inventions focus on methods for treating sexual dysfunction, such as erectile dysfunction or sexual arousal disorder, using specific compounds. One notable compound is HP-228, which has the formula Ac-Nle-Gln-His-(D)Phe-Arg-(D)Trp-Gly-NH. The inventions also provide methods for selecting melanocortin receptor-3 ligands by determining whether a compound modulates the activity of MC-3 as an agonist or antagonist. These methods can be utilized to screen compound libraries for ligands that address MC-3-associated conditions.

Career Highlights

Karen is currently employed at Lion Bioscience AG, where she continues to innovate and develop new therapeutic solutions. Her work is characterized by a strong focus on practical applications that can lead to improved health outcomes.

Collaborations

She collaborates with notable colleagues, including Timothy Gahman and Kevin Ross Holme, who contribute to her research and development efforts.

Conclusion

Karen J Watson-Straughan is a pioneering inventor whose work in the field of sexual dysfunction treatment showcases her dedication to improving health through innovative solutions. Her contributions are significant and reflect her commitment to advancing medical science.